Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › MLYS

SPHERA FUNDS MANAGEMENT LTD. position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

SPHERA FUNDS MANAGEMENT LTD. reported holding 1,469,971 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$39.7M, representing 5.54% of its reported portfolio and ranking #2 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed MLYS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.47M sh
Reported value held$39.66M
Portfolio Weight5.54%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SPHERA FUNDS MANAGEMENT LTD.'s MLYS position evolved

SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in MLYS in Q3 2023 at 455,400 shares (US$4.3M). The position peaked in Q2 2026 at 1,469,971 shares, worth US$39.7M. Across 12 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,469,971 shares valued at US$39.7M — an increase of 130,000 shares quarter over quarter.. Notable position changes include a 144% increase in Q1 2025 (shares fell 15% over the following quarter), a 104% increase in Q4 2025 (shares fell 25% over the following quarter), a 198% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 455.40K $4.33M New
Q4 2023 743.59K $6.39M Add
Q1 2024 658.80K $8.51M Reduce
Q2 2024 442.75K $5.18M Reduce
Q3 2024 272.47K $3.30M Reduce
Q4 2024 190.67K $2.35M Reduce
Q1 2025 465.53K $7.39M Add
Q2 2025 480.97K $6.51M Add
Q3 2025 219.91K $8.34M Reduce
Q4 2025 449.00K $16.29M Add
Q1 2026 1.34M $36.30M Add
Q2 2026 1.47M $39.66M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has SPHERA FUNDS MANAGEMENT LTD. held MLYS?

SPHERA FUNDS MANAGEMENT LTD. has disclosed MLYS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is SPHERA FUNDS MANAGEMENT LTD.'s current position in MLYS?

As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 1.47M shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $39.66M, representing 5.54% of its reported portfolio and ranking #2.

Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling MLYS?

In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. increased its position in MLYS. The position peaked in Q2 2026 at 1.47M shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.